-
Why Pharmaceuticals Are So Complicated In The U.S. | CNBC Marathon
CNBC Marathon explores why pharmaceuticals are so complicated in the United States.
Concerns over prescription drug prices have grown into a big political issue, with nearly one in four Americans saying it's difficult to afford their medications, according to a March 2019 poll by the Kaiser Family Foundation. Pharmacies technically set their own prices for generic drugs, but there are other players involved that complicate the process.
Johnson & Johnson, the biggest pharmaceutical company in the U.S. based on market cap, announced in November 2021 it plans to spin off its consumer business into a new publicly traded company by November 2023. Analysts overwhelmingly say it’s a smart business move, but it could also come with some risks.
Meanwhile, the U.S.'s approval of Biogen's Alzheimer...
published: 03 Jul 2022
-
The Birth of the Pharmaceutical Industry
Earlier in the series we talked about how it was the artificial dye industry that gave way to the pharmaceutical industry in the latter half of the 19th century. Let's now examine the first large pharma companies to emerge, and the products they were manufacturing at that time. This will include Farbwerke Höchst, Bayer, and E. Merck, which put themselves on the map by producing drugs like antipyrine, novocaine, aspirin, and even heroin. How did this industry get off the ground? What impact did World War I have on this process? Let's discuss all this and more!
Script by Vittorio Farina
Animation by Cyrene Domogalla: https://cyrenedomogalla.myportfolio.com/
Watch the full series: http://bit.ly/ProfDaveHistoryDrugs
Pharmacology Tutorials: http://bit.ly/ProfDavePharma
Immunology Tutorials: ...
published: 11 Feb 2022
-
The power of the pharmaceutical companies | DW Documentary
How much is a human life worth? An innovative cancer therapy promises to save lives. But it is extremely expensive. Will the insurance companies pay for it? What is the manufacturer's return on investment? And do lobbyists drive up prices?
In 2018, the Kymriah gene therapy was approved in Europe. Immune cells are taken from the patient, genetically reprogrammed into cancer killer cells and returned to the patient as an infusion. The results of the Kymriah study only cover a period of 18 months. In 40 percent of patients, lymph gland cancer does not return during this time. It is not clear whether Kymriah has a long-term effect. The Swiss pharmaceutical company Novartis offers the new therapy - it costs 370,000 Swiss francs per patient. Health insurance companies are not usually prepared t...
published: 28 Oct 2020
-
What is The Pharmaceutical Industry?
What everybody should know about Clinical Trials!
Without clinical trials, we wouldn’t have any vaccines, treatments for cancer, heart disease, diabetes and many others. What should everybody know about Clinical Trials? How are pharmaceuticals and medical devices developed? This is our new video of our series about the basics of clinical trials to give you some answers.
For more insight into our world of Clinical Research, and to be sure not to miss a thing,
Visit us on Instagram: https://www.instagram.com/gcpservice/
Tweet with us on: https://twitter.com/GcpService
LinkedIn: https://www.linkedin.com/company/gcp-service-international-ltd-co-kg
Xing: https://www.xing.com/pages/gcp-serviceinternationalltd-co-kg
Or even visit our Homepage: https://www.gcp-service.com/
It’s all about the ...
published: 13 Jan 2022
-
Big Pharma - How much power do drug companies have? | DW Documentary
The pharmaceutical industry exerts a huge amount of influence on health policy. Some companies develop highly profitable drugs with public money, while others have been found to have covered up serious side effects.
The fight against Covid-19 is further fueling the greed of pharmaceutical companies. Does the industry’s influence threaten public health systems?
The industry has seen major changes in the last decade. Most of the world’s pharmaceuticals are produced by a handful of large corporations, so-called Big Pharma. They’re richer and more powerful than ever. In some cases, they can even call the shots on governmental health policies.
This documentary is the result of more than a year of research, and brings together patients, whistleblowers, lawyers, doctors and politicians, as w...
published: 12 Sep 2021
-
GxP in Pharmaceuticals
GxP is complete good practices in all parts of the pharmaceutical manufacturing including GMP, GLP, GDP, GCP etc.
Details: https://www.pharmaguideline.com/2017/01/concept-of-gxp-in-pharmaceuticals.html
------------------------------------------------
Pharmaguideline provides all pharma information and pharmaceutical guidelines including information about testing procedures of quality control, calibration, reagents and solutions, glassware and good laboratory practices (GLP), audit checklists of all departments for QA professionals.
It also covers quality assurance topics such as change control, deviations, market complaints, process validation, cleaning validation cGMP and other pharma documentation and guideline. A fresher in the pharma field can get all latest information about GMP guide...
published: 21 Oct 2018
-
Understanding Pharmaceutical industry | Starweaver |
Understanding Pharmaceutical Industry
Entering the world of pharmaceuticals can seem like going into a black hole. From the nuances of drug discovery to the complexity of governmental regulations, understanding how pharmaceutical companies operate seems almost incomprehensible. However, by exploring some of the foundational building blocks of the industry you can begin to see what it takes for a drug to go from an idea to being dispensed at your local pharmacy.
During this course provides a deep dive into four key building blocks of the pharmaceutical industry:
Introduction to the Industry
Drug Discovery
Drug Development
Medical Affairs
This invaluable resource provides a rich overview of these critical components of the industry and describes who some of the main players are and wh...
published: 17 Dec 2019
-
Pharmacy vs Pharmaceutical Science: What's the difference?
Academics from our two main undergraduate courses talk about the difference between them. Which one is right for you?
published: 19 May 2021
-
Former Pharmaceutical Rep Details How Oxycontin Took Over
Taken from JRE #1873 w/Brigham Buhler:
https://open.spotify.com/episode/30NOm1ioG5mpmoQCNEjNgF?si=59f92850a6ec4576
published: 23 Sep 2022
-
How to Start a Pharmaceutical Company With Full Case Study? – [Hindi] – Quick Support
#HowtoStartaPharmaceuticalCompany? #QuickSupport #Career
How to Start a Pharmaceutical Company With Full Case Study? – [Hindi] – Quick Support. फार्मास्यूटिकल कंपनियां दिन - रात नयी नयी दवाइयों की खोज और डेवलपमेंट में लगी रहती हैं, ताकि लोगों की जान बचायी जा सके. जब तक इंसानी ज़िन्दगी मौजूद है, तब तक दवाइयों की ज़रुरत हमें पड़ती रहेगी. इसीलिए ये एक ऐसा फ़ील्ड है, जिसमें Endless Business Opportunities हैं. इसीलिए आज Quick Support आपको पूरी Case Study के साथ बताएगा की इंडिया में आप अपनी ख़ुद की फार्मा स्यूटिकल कंपनी कैसे शुरू कर सकते हैं. इसीलिए इस विडियो को पूरा जरुर देखे.
Website: https://qsofficial.com
Facebook: https://www.facebook.com/QuickSupportChannel
Twitter: https://twitter.com/QS_Channel
Instagram: https://www.instagram.com/quick_support007
Youtube: https://www.youtube.com/c/Qui...
published: 07 May 2021
1:01:48
Why Pharmaceuticals Are So Complicated In The U.S. | CNBC Marathon
CNBC Marathon explores why pharmaceuticals are so complicated in the United States.
Concerns over prescription drug prices have grown into a big political issue...
CNBC Marathon explores why pharmaceuticals are so complicated in the United States.
Concerns over prescription drug prices have grown into a big political issue, with nearly one in four Americans saying it's difficult to afford their medications, according to a March 2019 poll by the Kaiser Family Foundation. Pharmacies technically set their own prices for generic drugs, but there are other players involved that complicate the process.
Johnson & Johnson, the biggest pharmaceutical company in the U.S. based on market cap, announced in November 2021 it plans to spin off its consumer business into a new publicly traded company by November 2023. Analysts overwhelmingly say it’s a smart business move, but it could also come with some risks.
Meanwhile, the U.S.'s approval of Biogen's Alzheimer's drug Aduhelm was heralded as a historic triumph in the fight against the memory-robbing disease. But so far, Biogen has reported only a fraction of Aduhelm revenue to meet Wall Street's expectations. Patients and physicians have been torn over the drug's murky clinical data and its high price tag. Aduhelm's lackluster launch has been costly, forcing Biogen to take measures to keep the drug afloat.
For Covid-19 vaccine maker, BioNTech, they had little recognition outside of their hometown of Germany prior to the pandemic. Over a month and a half before the World Health Organization officially declared a pandemic, BioNTech CEO Uğur Şahin met with his wife, BioNTech’s co-founder and chief medical officer Özlem Türeci, and together they agreed to redirect most of the company’s resources to developing a vaccine. The founders were confident in the potential of their mRNA technology, which they knew could trigger a powerful immune response. That confidence wasn’t necessarily shared by the broader medical community. No mRNA vaccine or treatment had ever been approved before. But the couple’s timely breakthrough was actually decades in the making.
CNBC Marathon brings together the best of CNBC on YouTube.
Chapters:
00:00 Introduction
00:31 Why U.S. pharmacies overcharge (Published August 2021)
16:35 The rise of BioNTech (Published October 2021)
34:21 Why the biggest pharma company in the U.S. is breaking up (Published January 2022)
45:42 What’s the controversy behind Biogen’s Alzheimer’s drug? (Published January 2022)
» Subscribe to CNBC: http://cnb.cx/SubscribeCNBC
About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.
Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: http://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: http://cnb.cx/FollowCNBC
Follow CNBC News on Google+: http://cnb.cx/PlusCNBC
Follow CNBC News on Instagram: http://cnb.cx/InstagramCNBC
#cnbc
Why Pharmaceuticals Are So Complicated In The U.S. | CNBC Marathon
https://gemeentedelft.info/Why_Pharmaceuticals_Are_So_Complicated_In_The_U.S._|_Cnbc_Marathon
CNBC Marathon explores why pharmaceuticals are so complicated in the United States.
Concerns over prescription drug prices have grown into a big political issue, with nearly one in four Americans saying it's difficult to afford their medications, according to a March 2019 poll by the Kaiser Family Foundation. Pharmacies technically set their own prices for generic drugs, but there are other players involved that complicate the process.
Johnson & Johnson, the biggest pharmaceutical company in the U.S. based on market cap, announced in November 2021 it plans to spin off its consumer business into a new publicly traded company by November 2023. Analysts overwhelmingly say it’s a smart business move, but it could also come with some risks.
Meanwhile, the U.S.'s approval of Biogen's Alzheimer's drug Aduhelm was heralded as a historic triumph in the fight against the memory-robbing disease. But so far, Biogen has reported only a fraction of Aduhelm revenue to meet Wall Street's expectations. Patients and physicians have been torn over the drug's murky clinical data and its high price tag. Aduhelm's lackluster launch has been costly, forcing Biogen to take measures to keep the drug afloat.
For Covid-19 vaccine maker, BioNTech, they had little recognition outside of their hometown of Germany prior to the pandemic. Over a month and a half before the World Health Organization officially declared a pandemic, BioNTech CEO Uğur Şahin met with his wife, BioNTech’s co-founder and chief medical officer Özlem Türeci, and together they agreed to redirect most of the company’s resources to developing a vaccine. The founders were confident in the potential of their mRNA technology, which they knew could trigger a powerful immune response. That confidence wasn’t necessarily shared by the broader medical community. No mRNA vaccine or treatment had ever been approved before. But the couple’s timely breakthrough was actually decades in the making.
CNBC Marathon brings together the best of CNBC on YouTube.
Chapters:
00:00 Introduction
00:31 Why U.S. pharmacies overcharge (Published August 2021)
16:35 The rise of BioNTech (Published October 2021)
34:21 Why the biggest pharma company in the U.S. is breaking up (Published January 2022)
45:42 What’s the controversy behind Biogen’s Alzheimer’s drug? (Published January 2022)
» Subscribe to CNBC: http://cnb.cx/SubscribeCNBC
About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.
Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: http://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: http://cnb.cx/FollowCNBC
Follow CNBC News on Google+: http://cnb.cx/PlusCNBC
Follow CNBC News on Instagram: http://cnb.cx/InstagramCNBC
#cnbc
Why Pharmaceuticals Are So Complicated In The U.S. | CNBC Marathon
- published: 03 Jul 2022
- views: 683741
11:21
The Birth of the Pharmaceutical Industry
Earlier in the series we talked about how it was the artificial dye industry that gave way to the pharmaceutical industry in the latter half of the 19th century...
Earlier in the series we talked about how it was the artificial dye industry that gave way to the pharmaceutical industry in the latter half of the 19th century. Let's now examine the first large pharma companies to emerge, and the products they were manufacturing at that time. This will include Farbwerke Höchst, Bayer, and E. Merck, which put themselves on the map by producing drugs like antipyrine, novocaine, aspirin, and even heroin. How did this industry get off the ground? What impact did World War I have on this process? Let's discuss all this and more!
Script by Vittorio Farina
Animation by Cyrene Domogalla: https://cyrenedomogalla.myportfolio.com/
Watch the full series: http://bit.ly/ProfDaveHistoryDrugs
Pharmacology Tutorials: http://bit.ly/ProfDavePharma
Immunology Tutorials: http://bit.ly/ProfDaveImmuno
Microbiology/Infectious Diseases Tutorials: http://bit.ly/ProfDaveMicrobio
General Chemistry Tutorials: http://bit.ly/ProfDaveGenChem
Organic Chemistry Tutorials: http://bit.ly/ProfDaveOrgChem
Biochemistry Tutorials: http://bit.ly/ProfDaveBiochem
Biology/Genetics Tutorials: http://bit.ly/ProfDaveBio
Anatomy & Physiology Tutorials: http://bit.ly/ProfDaveAnatPhys
Biopsychology Tutorials: http://bit.ly/ProfDaveBiopsych
EMAIL►
[email protected]
PATREON► http://patreon.com/ProfessorDaveExplains
Check out "Is This Wi-Fi Organic?", my book on disarming pseudoscience!
Amazon: https://amzn.to/2HtNpVH
Bookshop: https://bit.ly/39cKADM
Barnes and Noble: https://bit.ly/3pUjmrn
Book Depository: http://bit.ly/3aOVDlT
https://gemeentedelft.info/The_Birth_Of_The_Pharmaceutical_Industry
Earlier in the series we talked about how it was the artificial dye industry that gave way to the pharmaceutical industry in the latter half of the 19th century. Let's now examine the first large pharma companies to emerge, and the products they were manufacturing at that time. This will include Farbwerke Höchst, Bayer, and E. Merck, which put themselves on the map by producing drugs like antipyrine, novocaine, aspirin, and even heroin. How did this industry get off the ground? What impact did World War I have on this process? Let's discuss all this and more!
Script by Vittorio Farina
Animation by Cyrene Domogalla: https://cyrenedomogalla.myportfolio.com/
Watch the full series: http://bit.ly/ProfDaveHistoryDrugs
Pharmacology Tutorials: http://bit.ly/ProfDavePharma
Immunology Tutorials: http://bit.ly/ProfDaveImmuno
Microbiology/Infectious Diseases Tutorials: http://bit.ly/ProfDaveMicrobio
General Chemistry Tutorials: http://bit.ly/ProfDaveGenChem
Organic Chemistry Tutorials: http://bit.ly/ProfDaveOrgChem
Biochemistry Tutorials: http://bit.ly/ProfDaveBiochem
Biology/Genetics Tutorials: http://bit.ly/ProfDaveBio
Anatomy & Physiology Tutorials: http://bit.ly/ProfDaveAnatPhys
Biopsychology Tutorials: http://bit.ly/ProfDaveBiopsych
EMAIL►
[email protected]
PATREON► http://patreon.com/ProfessorDaveExplains
Check out "Is This Wi-Fi Organic?", my book on disarming pseudoscience!
Amazon: https://amzn.to/2HtNpVH
Bookshop: https://bit.ly/39cKADM
Barnes and Noble: https://bit.ly/3pUjmrn
Book Depository: http://bit.ly/3aOVDlT
- published: 11 Feb 2022
- views: 106574
42:27
The power of the pharmaceutical companies | DW Documentary
How much is a human life worth? An innovative cancer therapy promises to save lives. But it is extremely expensive. Will the insurance companies pay for it? Wha...
How much is a human life worth? An innovative cancer therapy promises to save lives. But it is extremely expensive. Will the insurance companies pay for it? What is the manufacturer's return on investment? And do lobbyists drive up prices?
In 2018, the Kymriah gene therapy was approved in Europe. Immune cells are taken from the patient, genetically reprogrammed into cancer killer cells and returned to the patient as an infusion. The results of the Kymriah study only cover a period of 18 months. In 40 percent of patients, lymph gland cancer does not return during this time. It is not clear whether Kymriah has a long-term effect. The Swiss pharmaceutical company Novartis offers the new therapy - it costs 370,000 Swiss francs per patient. Health insurance companies are not usually prepared to pay that much and are complaining about a lack of transparency.
But the killer cells were not invented in the Novartis laboratories, but at a US university. When Professor Carl June started his research almost 30 years ago, no pharmaceutical company was interested. It was only thanks to funding from tax money and donations that he was able to develop Kymriah at all. After a story went around the world about a girl with leukemia whose cancer disappeared thanks to Kymriah, the pharmaceutical company contacted Novartis and secured exclusive marketing rights. To launch Kymriah on the market, Novartis funded the necessary clinical trials. It's not an isolated incident: Over 60% of newly approved medicines in the US are developed by small biotech companies or universities. Pharmaceutical companies today frequently act as capital providers, cooperating with universities or buying up biotech companies.
A paradigm shift has taken place in the pharmaceutical industry: Whereas high drug prices used to be justified by research costs, the industry is now using the value of gained lifetime to argue its case.
-------------------------------------------------------------------
DW Documentary gives you knowledge beyond the headlines. Watch high-class documentaries from German broadcasters and international production companies. Meet intriguing people, travel to distant lands, get a look behind the complexities of daily life and build a deeper understanding of current affairs and global events. Subscribe and explore the world around you with DW Documentary.
Subscribe to:
DW Documentary: https://www.youtube.com/channel/UCW39zufHfsuGgpLviKh297Q?sub_confirmation=1#
DW Documental (Spanish): https://www.youtube.com/dwdocumental
DW Documentary وثائقية دي دبليو: (Arabic): https://www.youtube.com/dwdocarabia
For more visit:
http://www.dw.com/en/tv/docfilm/s-3610
Instagram:
https://www.instagram.com/dwdocumentary/
Facebook:
https://www.facebook.com/dw.stories
DW netiquette policy: https://p.dw.com/p/MF1G
https://gemeentedelft.info/The_Power_Of_The_Pharmaceutical_Companies_|_Dw_Documentary
How much is a human life worth? An innovative cancer therapy promises to save lives. But it is extremely expensive. Will the insurance companies pay for it? What is the manufacturer's return on investment? And do lobbyists drive up prices?
In 2018, the Kymriah gene therapy was approved in Europe. Immune cells are taken from the patient, genetically reprogrammed into cancer killer cells and returned to the patient as an infusion. The results of the Kymriah study only cover a period of 18 months. In 40 percent of patients, lymph gland cancer does not return during this time. It is not clear whether Kymriah has a long-term effect. The Swiss pharmaceutical company Novartis offers the new therapy - it costs 370,000 Swiss francs per patient. Health insurance companies are not usually prepared to pay that much and are complaining about a lack of transparency.
But the killer cells were not invented in the Novartis laboratories, but at a US university. When Professor Carl June started his research almost 30 years ago, no pharmaceutical company was interested. It was only thanks to funding from tax money and donations that he was able to develop Kymriah at all. After a story went around the world about a girl with leukemia whose cancer disappeared thanks to Kymriah, the pharmaceutical company contacted Novartis and secured exclusive marketing rights. To launch Kymriah on the market, Novartis funded the necessary clinical trials. It's not an isolated incident: Over 60% of newly approved medicines in the US are developed by small biotech companies or universities. Pharmaceutical companies today frequently act as capital providers, cooperating with universities or buying up biotech companies.
A paradigm shift has taken place in the pharmaceutical industry: Whereas high drug prices used to be justified by research costs, the industry is now using the value of gained lifetime to argue its case.
-------------------------------------------------------------------
DW Documentary gives you knowledge beyond the headlines. Watch high-class documentaries from German broadcasters and international production companies. Meet intriguing people, travel to distant lands, get a look behind the complexities of daily life and build a deeper understanding of current affairs and global events. Subscribe and explore the world around you with DW Documentary.
Subscribe to:
DW Documentary: https://www.youtube.com/channel/UCW39zufHfsuGgpLviKh297Q?sub_confirmation=1#
DW Documental (Spanish): https://www.youtube.com/dwdocumental
DW Documentary وثائقية دي دبليو: (Arabic): https://www.youtube.com/dwdocarabia
For more visit:
http://www.dw.com/en/tv/docfilm/s-3610
Instagram:
https://www.instagram.com/dwdocumentary/
Facebook:
https://www.facebook.com/dw.stories
DW netiquette policy: https://p.dw.com/p/MF1G
- published: 28 Oct 2020
- views: 673987
3:58
What is The Pharmaceutical Industry?
What everybody should know about Clinical Trials!
Without clinical trials, we wouldn’t have any vaccines, treatments for cancer, heart disease, diabetes and man...
What everybody should know about Clinical Trials!
Without clinical trials, we wouldn’t have any vaccines, treatments for cancer, heart disease, diabetes and many others. What should everybody know about Clinical Trials? How are pharmaceuticals and medical devices developed? This is our new video of our series about the basics of clinical trials to give you some answers.
For more insight into our world of Clinical Research, and to be sure not to miss a thing,
Visit us on Instagram: https://www.instagram.com/gcpservice/
Tweet with us on: https://twitter.com/GcpService
LinkedIn: https://www.linkedin.com/company/gcp-service-international-ltd-co-kg
Xing: https://www.xing.com/pages/gcp-serviceinternationalltd-co-kg
Or even visit our Homepage: https://www.gcp-service.com/
It’s all about the mindset, the GCP-Mindset 💡
https://gemeentedelft.info/What_Is_The_Pharmaceutical_Industry
What everybody should know about Clinical Trials!
Without clinical trials, we wouldn’t have any vaccines, treatments for cancer, heart disease, diabetes and many others. What should everybody know about Clinical Trials? How are pharmaceuticals and medical devices developed? This is our new video of our series about the basics of clinical trials to give you some answers.
For more insight into our world of Clinical Research, and to be sure not to miss a thing,
Visit us on Instagram: https://www.instagram.com/gcpservice/
Tweet with us on: https://twitter.com/GcpService
LinkedIn: https://www.linkedin.com/company/gcp-service-international-ltd-co-kg
Xing: https://www.xing.com/pages/gcp-serviceinternationalltd-co-kg
Or even visit our Homepage: https://www.gcp-service.com/
It’s all about the mindset, the GCP-Mindset 💡
- published: 13 Jan 2022
- views: 3833
42:27
Big Pharma - How much power do drug companies have? | DW Documentary
The pharmaceutical industry exerts a huge amount of influence on health policy. Some companies develop highly profitable drugs with public money, while others h...
The pharmaceutical industry exerts a huge amount of influence on health policy. Some companies develop highly profitable drugs with public money, while others have been found to have covered up serious side effects.
The fight against Covid-19 is further fueling the greed of pharmaceutical companies. Does the industry’s influence threaten public health systems?
The industry has seen major changes in the last decade. Most of the world’s pharmaceuticals are produced by a handful of large corporations, so-called Big Pharma. They’re richer and more powerful than ever. In some cases, they can even call the shots on governmental health policies.
This documentary is the result of more than a year of research, and brings together patients, whistleblowers, lawyers, doctors and politicians, as well as representatives of the industry. Large laboratories are accused of concealing or downplaying research results to maintain their monopolies. Take the manufacturer Sanofi, whose epilepsy drug Depakine triggered a scandal throughout Europe. In the US, Johnson & Johnson has had to stand trial for driving millions of people into opioid addiction. And Novartis is one of several companies now facing huge fines over improper practices in the treatment of macular degeneration, an eye disease.
The pharmaceutical industry gets support from influential doctors. But only one-fifth of German doctors declare what they receive from drug companies. As the world battles the Coronavirus pandemic, this documentary also looks at the lobbying efforts of manufacturer Gilead, as it seeks approval for a promising drug developed largely with public money. Every company is vying to find the next miracle treatment that will help it succeed against the competition.
#documentary #BigPharma #dwdocumentary
______
DW Documentary gives you knowledge beyond the headlines. Watch top documentaries from German broadcasters and international production companies. Meet intriguing people, travel to distant lands, get a look behind the complexities of daily life and build a deeper understanding of current affairs and global events. Subscribe and explore the world around you with DW Documentary.
Subscribe to:
⮞ DW Documentary (English): https://www.youtube.com/dwdocumentary
⮞ DW Documental (Spanish): https://www.youtube.com/dwdocumental
⮞ DW Documentary (Arabic): https://www.youtube.com/dwdocarabia
⮞ DW Doku (German): https://www.youtube.com/channel/UCH1kA4LQsyjKeW0mPLOAdGQ
⮞ DW Documentary (Hindi): https://www.youtube.com/channel/UC46ccgpPJK-3wLzzQrLGtSg
For more visit: http://www.dw.com/en/tv/docfilm/s-3610
Follow DW Documentary on Instagram: https://www.instagram.com/dwdocumentary/
Follow DW Documental on Facebook: https://www.facebook.com/dwdocumental
We kindly ask viewers to read and stick to the DW netiquette policy on our channel: https://p.dw.com/p/MF1G
https://gemeentedelft.info/Big_Pharma_How_Much_Power_Do_Drug_Companies_Have_|_Dw_Documentary
The pharmaceutical industry exerts a huge amount of influence on health policy. Some companies develop highly profitable drugs with public money, while others have been found to have covered up serious side effects.
The fight against Covid-19 is further fueling the greed of pharmaceutical companies. Does the industry’s influence threaten public health systems?
The industry has seen major changes in the last decade. Most of the world’s pharmaceuticals are produced by a handful of large corporations, so-called Big Pharma. They’re richer and more powerful than ever. In some cases, they can even call the shots on governmental health policies.
This documentary is the result of more than a year of research, and brings together patients, whistleblowers, lawyers, doctors and politicians, as well as representatives of the industry. Large laboratories are accused of concealing or downplaying research results to maintain their monopolies. Take the manufacturer Sanofi, whose epilepsy drug Depakine triggered a scandal throughout Europe. In the US, Johnson & Johnson has had to stand trial for driving millions of people into opioid addiction. And Novartis is one of several companies now facing huge fines over improper practices in the treatment of macular degeneration, an eye disease.
The pharmaceutical industry gets support from influential doctors. But only one-fifth of German doctors declare what they receive from drug companies. As the world battles the Coronavirus pandemic, this documentary also looks at the lobbying efforts of manufacturer Gilead, as it seeks approval for a promising drug developed largely with public money. Every company is vying to find the next miracle treatment that will help it succeed against the competition.
#documentary #BigPharma #dwdocumentary
______
DW Documentary gives you knowledge beyond the headlines. Watch top documentaries from German broadcasters and international production companies. Meet intriguing people, travel to distant lands, get a look behind the complexities of daily life and build a deeper understanding of current affairs and global events. Subscribe and explore the world around you with DW Documentary.
Subscribe to:
⮞ DW Documentary (English): https://www.youtube.com/dwdocumentary
⮞ DW Documental (Spanish): https://www.youtube.com/dwdocumental
⮞ DW Documentary (Arabic): https://www.youtube.com/dwdocarabia
⮞ DW Doku (German): https://www.youtube.com/channel/UCH1kA4LQsyjKeW0mPLOAdGQ
⮞ DW Documentary (Hindi): https://www.youtube.com/channel/UC46ccgpPJK-3wLzzQrLGtSg
For more visit: http://www.dw.com/en/tv/docfilm/s-3610
Follow DW Documentary on Instagram: https://www.instagram.com/dwdocumentary/
Follow DW Documental on Facebook: https://www.facebook.com/dwdocumental
We kindly ask viewers to read and stick to the DW netiquette policy on our channel: https://p.dw.com/p/MF1G
- published: 12 Sep 2021
- views: 2641560
6:08
GxP in Pharmaceuticals
GxP is complete good practices in all parts of the pharmaceutical manufacturing including GMP, GLP, GDP, GCP etc.
Details: https://www.pharmaguideline.com/2017/...
GxP is complete good practices in all parts of the pharmaceutical manufacturing including GMP, GLP, GDP, GCP etc.
Details: https://www.pharmaguideline.com/2017/01/concept-of-gxp-in-pharmaceuticals.html
------------------------------------------------
Pharmaguideline provides all pharma information and pharmaceutical guidelines including information about testing procedures of quality control, calibration, reagents and solutions, glassware and good laboratory practices (GLP), audit checklists of all departments for QA professionals.
It also covers quality assurance topics such as change control, deviations, market complaints, process validation, cleaning validation cGMP and other pharma documentation and guideline. A fresher in the pharma field can get all latest information about GMP guidelines for QA, QC, Production and Microbiology.
Pharmaceutical Guidelines App provides all recent pharma news updates from the world with the alert for free.
New articles are added every day to enhance the knowledge of pharmaceutical professionals. All pharmaceutical stuff can be found in one place. About 2500 topics have been covered to date and counting.
Pharmaguideline is the total pharmaceutical solution for professionals as well as students.
Join us
Youtube - https://go.pharmaguideline.com/youtube
Facebook -https://go.pharmaguideline.com/facebook
LinkedIn - https://go.pharmaguideline.com/linkedin
Twitter - https://go.pharmaguideline.com/twitter
Blog - https://www.pharmaguiseline.com
https://gemeentedelft.info/Gxp_In_Pharmaceuticals
GxP is complete good practices in all parts of the pharmaceutical manufacturing including GMP, GLP, GDP, GCP etc.
Details: https://www.pharmaguideline.com/2017/01/concept-of-gxp-in-pharmaceuticals.html
------------------------------------------------
Pharmaguideline provides all pharma information and pharmaceutical guidelines including information about testing procedures of quality control, calibration, reagents and solutions, glassware and good laboratory practices (GLP), audit checklists of all departments for QA professionals.
It also covers quality assurance topics such as change control, deviations, market complaints, process validation, cleaning validation cGMP and other pharma documentation and guideline. A fresher in the pharma field can get all latest information about GMP guidelines for QA, QC, Production and Microbiology.
Pharmaceutical Guidelines App provides all recent pharma news updates from the world with the alert for free.
New articles are added every day to enhance the knowledge of pharmaceutical professionals. All pharmaceutical stuff can be found in one place. About 2500 topics have been covered to date and counting.
Pharmaguideline is the total pharmaceutical solution for professionals as well as students.
Join us
Youtube - https://go.pharmaguideline.com/youtube
Facebook -https://go.pharmaguideline.com/facebook
LinkedIn - https://go.pharmaguideline.com/linkedin
Twitter - https://go.pharmaguideline.com/twitter
Blog - https://www.pharmaguiseline.com
- published: 21 Oct 2018
- views: 16390
5:25
Understanding Pharmaceutical industry | Starweaver |
Understanding Pharmaceutical Industry
Entering the world of pharmaceuticals can seem like going into a black hole. From the nuances of drug discovery to the ...
Understanding Pharmaceutical Industry
Entering the world of pharmaceuticals can seem like going into a black hole. From the nuances of drug discovery to the complexity of governmental regulations, understanding how pharmaceutical companies operate seems almost incomprehensible. However, by exploring some of the foundational building blocks of the industry you can begin to see what it takes for a drug to go from an idea to being dispensed at your local pharmacy.
During this course provides a deep dive into four key building blocks of the pharmaceutical industry:
Introduction to the Industry
Drug Discovery
Drug Development
Medical Affairs
This invaluable resource provides a rich overview of these critical components of the industry and describes who some of the main players are and what they do. This program also sets the context and prepares you for further exploration into this fascinating industry.
===============
This short segment is part of a full course available at:
https://go.starweaver.com/courses/understanding-pharma
Those who complete the full course, will be able to
Describe the industry’s size and scope
Articulate the industry’s contribution to global health
Describe the regulatory environment governing the industry
Understand the mission of discovery in the industry
Describe the “anatomy” of a clinical trial
Understand the Medical Affairs function’s many responsibilities
This program is conducted by Kris Kristensen, a leading expert in the heath care business.
===============
For organizations or teams interested in the full program (including volume discounts), visit our website, chat with customer support and/or contact our customer success team at:
[email protected]
https://gemeentedelft.info/Understanding_Pharmaceutical_Industry_|_Starweaver_|
Understanding Pharmaceutical Industry
Entering the world of pharmaceuticals can seem like going into a black hole. From the nuances of drug discovery to the complexity of governmental regulations, understanding how pharmaceutical companies operate seems almost incomprehensible. However, by exploring some of the foundational building blocks of the industry you can begin to see what it takes for a drug to go from an idea to being dispensed at your local pharmacy.
During this course provides a deep dive into four key building blocks of the pharmaceutical industry:
Introduction to the Industry
Drug Discovery
Drug Development
Medical Affairs
This invaluable resource provides a rich overview of these critical components of the industry and describes who some of the main players are and what they do. This program also sets the context and prepares you for further exploration into this fascinating industry.
===============
This short segment is part of a full course available at:
https://go.starweaver.com/courses/understanding-pharma
Those who complete the full course, will be able to
Describe the industry’s size and scope
Articulate the industry’s contribution to global health
Describe the regulatory environment governing the industry
Understand the mission of discovery in the industry
Describe the “anatomy” of a clinical trial
Understand the Medical Affairs function’s many responsibilities
This program is conducted by Kris Kristensen, a leading expert in the heath care business.
===============
For organizations or teams interested in the full program (including volume discounts), visit our website, chat with customer support and/or contact our customer success team at:
[email protected]
- published: 17 Dec 2019
- views: 91122
2:00
Pharmacy vs Pharmaceutical Science: What's the difference?
Academics from our two main undergraduate courses talk about the difference between them. Which one is right for you?
Academics from our two main undergraduate courses talk about the difference between them. Which one is right for you?
https://gemeentedelft.info/Pharmacy_Vs_Pharmaceutical_Science_What's_The_Difference
Academics from our two main undergraduate courses talk about the difference between them. Which one is right for you?
- published: 19 May 2021
- views: 18142
14:52
Former Pharmaceutical Rep Details How Oxycontin Took Over
Taken from JRE #1873 w/Brigham Buhler:
https://open.spotify.com/episode/30NOm1ioG5mpmoQCNEjNgF?si=59f92850a6ec4576
Taken from JRE #1873 w/Brigham Buhler:
https://open.spotify.com/episode/30NOm1ioG5mpmoQCNEjNgF?si=59f92850a6ec4576
https://gemeentedelft.info/Former_Pharmaceutical_Rep_Details_How_Oxycontin_Took_Over
Taken from JRE #1873 w/Brigham Buhler:
https://open.spotify.com/episode/30NOm1ioG5mpmoQCNEjNgF?si=59f92850a6ec4576
- published: 23 Sep 2022
- views: 2567177
11:23
How to Start a Pharmaceutical Company With Full Case Study? – [Hindi] – Quick Support
#HowtoStartaPharmaceuticalCompany? #QuickSupport #Career
How to Start a Pharmaceutical Company With Full Case Study? – [Hindi] – Quick Support. फार्मास्यूटिकल ...
#HowtoStartaPharmaceuticalCompany? #QuickSupport #Career
How to Start a Pharmaceutical Company With Full Case Study? – [Hindi] – Quick Support. फार्मास्यूटिकल कंपनियां दिन - रात नयी नयी दवाइयों की खोज और डेवलपमेंट में लगी रहती हैं, ताकि लोगों की जान बचायी जा सके. जब तक इंसानी ज़िन्दगी मौजूद है, तब तक दवाइयों की ज़रुरत हमें पड़ती रहेगी. इसीलिए ये एक ऐसा फ़ील्ड है, जिसमें Endless Business Opportunities हैं. इसीलिए आज Quick Support आपको पूरी Case Study के साथ बताएगा की इंडिया में आप अपनी ख़ुद की फार्मा स्यूटिकल कंपनी कैसे शुरू कर सकते हैं. इसीलिए इस विडियो को पूरा जरुर देखे.
Website: https://qsofficial.com
Facebook: https://www.facebook.com/QuickSupportChannel
Twitter: https://twitter.com/QS_Channel
Instagram: https://www.instagram.com/quick_support007
Youtube: https://www.youtube.com/c/QuickSupport
Linkedin: https://www.linkedin.com/in/Anil-Nakrani
Channel Owner: Anil Nakrani
https://gemeentedelft.info/How_To_Start_A_Pharmaceutical_Company_With_Full_Case_Study_–_Hindi_–_Quick_Support
#HowtoStartaPharmaceuticalCompany? #QuickSupport #Career
How to Start a Pharmaceutical Company With Full Case Study? – [Hindi] – Quick Support. फार्मास्यूटिकल कंपनियां दिन - रात नयी नयी दवाइयों की खोज और डेवलपमेंट में लगी रहती हैं, ताकि लोगों की जान बचायी जा सके. जब तक इंसानी ज़िन्दगी मौजूद है, तब तक दवाइयों की ज़रुरत हमें पड़ती रहेगी. इसीलिए ये एक ऐसा फ़ील्ड है, जिसमें Endless Business Opportunities हैं. इसीलिए आज Quick Support आपको पूरी Case Study के साथ बताएगा की इंडिया में आप अपनी ख़ुद की फार्मा स्यूटिकल कंपनी कैसे शुरू कर सकते हैं. इसीलिए इस विडियो को पूरा जरुर देखे.
Website: https://qsofficial.com
Facebook: https://www.facebook.com/QuickSupportChannel
Twitter: https://twitter.com/QS_Channel
Instagram: https://www.instagram.com/quick_support007
Youtube: https://www.youtube.com/c/QuickSupport
Linkedin: https://www.linkedin.com/in/Anil-Nakrani
Channel Owner: Anil Nakrani
- published: 07 May 2021
- views: 325879